title: Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma.
authors.forename: Ngozi E
authors.initials: NE
authors.lastname: Dufty
authors.forename: Gerry
authors.initials: G
authors.lastname: Gilleran
authors.forename: Daniel
authors.initials: D
authors.lastname: Hawkins
authors.forename: Laura J
authors.initials: LJ
authors.lastname: Else
authors.forename: Stephen
authors.initials: S
authors.lastname: Taylor
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006528:Carcinoma, Hepatocellular / Q000601:surgery; D003510:Cyclohexanes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D016031:Liver Transplantation; D008297:Male; D000077592:Maraviroc; D008875:Middle Aged; D010949:Plasma / Q000737:chemistry; D016559:Tacrolimus / Q000008:administration & dosage / Q000493:pharmacokinetics*; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D019380:Anti-HIV Agents; D003510:Cyclohexanes; D007166:Immunosuppressive Agents; D014230:Triazoles; D000077592:Maraviroc; D016559:Tacrolimus